Community pharmacists’ attitudes and knowledge on dispensing drugs to pregnant women
The present study aimed to assess knowledge and attitudes of the pharmacists on dispensing drugs to pregnant women.
Methods: Cross-sectional study in 150 community pharmacies randomly selected in Curitiba (Brazil). A closed end questionnaire with 25 questions were used, including dispensing scenarios containing risk types A, B, D or X and questions on pharmacist interaction with pregnant women, physicians, and information sources availability.
Results: Pharmacists performed appropriately in 53% of the encounters. Lower success were associated to prednison and captopril (24.8% in both), end cases producing more doubts were captopril (31.7%) and simvastatin (30.7%). Most of the pharmacists state have advised drugs to pregnant women or contact to the physician to discuss about a prescription related with this issue. A Majority (64.4%) did not feel able to understand FDA risk classification and did not have trustable information sources in pharmacy.
Conclusions: Pharmacists dispensing drugs in Curitiba are not able to interpret information on the use of drugs in pregnant women, and they don have reliable information sources on the use of dugs in pregnancy. However, they advice and counsel drugs to pregnant women and discuss with physicians therapeutic strategies.
2 Mengue, SS, Schenkel, EP, Duncan, BB et al. Uso de medicamentos por gestantes em seis cidades brasileiras. Rev. Saúde Pública 2001;35(5):415-20.
3 CARMO, T.A. do.; NITRINI, S.M.O.O. Prescrições de medicamentos para gestantes: um estudo farmacoepidemiológico. Cad Saúde Pública 2004;20(4):1004-13.
4 McElhatton, P.R. General principles of drug use in pregnancy. Pharm J 2003; (270):232-4.
5 Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 6 Ed. Philadelphia: Lippincott; 2002.
6 Meadows M. Pregnancy and the drug dilemma. FDA Consumer Magazine [serial online] 2001; http://www.fda.gov/fdac/features/2001/301_preg.html (acessado em 28/03/2006).
7 Osório-de-Castro, C.G.S. Paumgartten, F.J.R. Silver, LD. O uso de medicamentos na gravidez. Ciência & Saúde Coletiva, 9(4):987-996, 2004.
8 Theunissen I. Treatment of benign symptoms during pregnancy: advice for the community pharmacist. J Pharm Belg 1992;47(1):30-2.
9 Damase-Michel C, Vie C, Lacroix I, Lapeyre-Mestre M, Montastruc JL. Drug counselling in pregnancy: an opinion survey of French community pharmacists. Pharmacoepidemiol Drug Saf 2004;13(10):711-5.
10 Lyszkiewicz DA, Gerichhausen S, Bjornsdottir I, Einarson TR, Koren G, Einarson A. Evidence based information on drug use during pregnancy: a survey of community pharmacists in three countries. Pharm World Sci. 2001;23(2):76-81.
11 Silva LR, Vieira EM. Pharmacists' knowledge of sanitary legislation and professional regulations. Rev Saude Publica 2004;38(3):429-37.
12 Ramos MC, da Silva RD, Gobbato RO et al. Pharmacy clerks' prescribing practices for STD patients in Porto Alegre, Brazil: missed opportunities for improving STD control. Int J STD AIDS. 2004 May;15(5):333-6.
13 Cadore LP, da Silva Marc C, Berti C. Pharmacy Distribution of Advice, Symptomatic Treatment and Antimicrobial Drugs to Patients with Cough. Braz J Infect Dis 1999;3(5):180-183.
14 PMB – IMS/Health. Lista dos 300 medicamentos mais vendidos na Brasil em valores totais. Disponível em:
15 Correr CJ, Rossignoli PS, Souza RAP, Pontarolo R. Profile of pharmacists and structure and process indicators of Curitiba-PR (Brazil) pharmacies. Seguimiento Farmacoterapeutico 2004; 2(1): 37-45.
16 de França Fº, JB. Pharmacist’s profile and structure and process indicators in community pharmacies in Santa Catarina State. Curitiba, 2005, 85f. Monografia (Especialização em Ciências Farmacêuticas). Departamento de Farmácia. Universidade Federal do Paraná.
17 Barros JAC. A (des)informação sobre medicamentos: o duplo padrão de conduta das empresas farmacêuticas. Cad. Saúde Pública 2000; 16(2):421-27.
The authors hereby transfer, assign, or otherwise convey to Pharmacy Practice: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print pr epublish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to Pharmacy Practice with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.